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Abstract
 
Structural rearrangements of the short arm of chromosome 12 are frequent cytogenetic findings in various
 
hematologic malignancies. The 
 
ETV6
 
 gene is the most common target for rearrangements in 12p13. Fluor-
escence in situ hybridization (FISH) investigations have shown that translocations of 12p other than t(12;21)
are frequently accompanied by small interstitial deletions that include 
 
ETV6
 
. Unbalanced translocations
involving 
 
ETV6
 
 have rarely been described, and breakpoints outside 
 
ETV6
 
 appear to be strongly associ-
ated with complex karyotypes. We studied bone marrow samples from 19 patients known to have 12p un-
balanced translocations and complex karyotypes, using FISH and spectral karyotyping. FISH analysis
confirmed the hemizygous deletion of the 
 
ETV6
 
 and 
 
CDKN1B
 
 genes in 74% of cases. We found four
cases with interstitial deletions. In these four cases and in two others (6/19, 31.5%), the fusion with the
partner chromosome was in the subtelomeric region of 12p13.3, confirming that there is a recurrent break-
 
point in this region. © 2003 Elsevier Science Inc. All rights reserved.
 
1. Introduction
 
The short arm of chromosome 12 is frequently rear-
ranged in hematologic malignancies of both myelocytic and
lymphoid origin. The abnormalities include deletions and
balanced and unbalanced translocations [1]. The 
 
ETV6
 
 gene
(formerly called 
 
TEL
 
), a member of the 
 
ETS
 
 family of tran-
scription factors, is the most common target for rearrange-
ments in 12p13 [1,2]. Since its initial description, 
 
ETV6
 
 has
been found rearranged with more than 40 chromosome
bands [3]. To date, 17 partner genes have been identified
and cloned; however, several other genes mapping to 12p13
could also be relevant in leukemogenesis, including
 
CDKN1B/KIP1
 
, an important negative regulator of the cell
cycle.
The 
 
ETV6-CBFA2
 
 fusion gene, resulting from a subtle
t(12;21), has been characterized as the most common ge-
netic lesion in pediatric acute lymphoblastic leukemia
(ALL); it is associated with a favorable outcome. Fre-
quently, this translocation is accompanied by the loss of the
other 
 
ETV
 
6 allele [4–6], although this is a secondary event
in ALL [7]. However, Andreasson et al. [8], reported that
expression of 
 
ETV6-CBFA2
 
 is not sufficient for induction
of growth factor independence in hematopoietic cell lines or
hematologic disease in transgenic mice, and they concluded
that additional genetic events, such as the deletion of the
second wild-type 
 
ETV6
 
 allele, are important steps required
for the development of 
 
ETV6-CBFA2
 
 ALL. Furthermore,
fluorescence in situ hybridization (FISH) analyses have
shown that translocations of 12p other than t(12;21) are fre-
quently accompanied by small interstitial deletions, which
may include 
 
ETV6
 
 [9–12]. These deletions in some cases
are different from the region reported in 
 
ETV6-CBFA2
 
 posi-
tive ALL [12]. Unbalanced translocations involving 
 
ETV6
 
have rarely been described [13,14], and cases with break-
points outside 
 
ETV6
 
 appear to be strongly associated with
complex karyotypes [14,15].
To define the chromosomal breakpoints and the region
deleted, we studied bone marrow samples from 19 patients
known to have 12p unbalanced translocations using FISH.
 
2. Patients and methods
 
Nineteen patients with hematologic malignancies and
12p unbalanced rearrangements studied at the University of
Chicago (USA) (14 patients) and at the University of Na-
varra (Spain) (5 patients) are included in the present report.
All samples were obtained with informed consent. Three pa-
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tients had acute myelocytic leukemia (AML) de novo, four
secondary AML, four myelodysplastic syndrome (MDS), one
biphenotypic acute leukemia, six ALL, and one mycosis fun-
goides (a lymphoproliferative disorder: LPD). 
Cytogenetic studies were done on unstimulated short-term
cultures. Giemsa-banded karyotypes were described accord-
ing to International System for Human Cytogenetic Nomencla-
ture (ISCN 1995) [16]. FISH analysis was performed using
12 cosmid and 3 phage probes located on 12p12.1 to 12p13.3,
as previously described [3]. 
 
ETV6/TEL
 
 was analyzed by
5 cosmids that cover the gene, and 
 
KIP1/CDKNIB
 
 using two
P1 phage clones [17,18]. The order of the probes is shown in
Fig. 1. The spectral karyotyping (SKY) probe mixture and
hybridization reagents were obtained from Applied Spectral
Imaging (Carlsbad, CA, USA). Slides for SKY were hybrid-
ized with the probe cocktail as previously described [19].
 
3. Results and discussion
 
One allele of 
 
ETV6
 
 and 
 
CDKN1B
 
 was deleted in 14 of 19
cases (74%). In 10 cases (1, 3, 5, 6, 7, 8, 9, 10, 12, and 14), the
breakpoint was centromeric to 
 
ETV6
 
 and 
 
CDKN1B
 
 and re-
sulted in the deletion of both genes as well as all other genes
on distal 12p (Fig. 1). In case 13, the breakpoint was centro-
meric to 
 
CDKN1B
 
, between P1-2097 and cos1C3, but both
FISH and SKY analyses showed the 12p13 region was in the
der(11) (Fig. 2A). We detected four other cases (11, 16, 17,
and 19) with unbalanced translocations that also had large
interstitial deletions similar to cases with del(12)(p12p13),
with breakpoints both centromeric and telomeric to 
 
ETV6
 
,
resulting in loss of 
 
ETV6
 
 and 
 
CDKN1B
 
. Interstitial deletions
of 12p are known to occur frequently in primary and sec-
ondary MDS and in other hematologic malignancies, espe-
cially of myelocytic origin [1], however, few cases have
been described in 12p unbalanced translocations. In all four
of our cases, the most telomeric probes we used were re-
tained, including cosmid 9A4, specific for the locus D12S235,
indicating that the junction with the other chromosome was
near to the telomeric region. In four patients—two with
ALL (cases 2 and 4), one mycosis fungoides (case 15), and
one MDS (case 18)—the breakpoint was telomeric to 
 
ETV6
 
(Fig. 1). In the two ALL patients, it was telomeric to D12S235
(Fig. 2B), similar to cases 11, 16, 17, and 19. These data
confirm the results of a recent report regarding a recurrent
Fig. 1. Results of FISH analysis of 19 patients with 12p unbalanced translocations. Cases 11, 16, 17, and 19 (dashed arrows) had a normal chromosome 12
and a der(12) with three breakpoints on 12p; the junction with the partner chromosome was telomeric to the 9A4 probe. These four cases had an interstitial
deletion with two breakpoints, centromeric and telomeric to ETV6, resulting in deletion of ETV6 and CDKN1B. The probes used in the hybridization are
shown on the left.
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breakpoint in the subtelomeric region of 12p [14]. The lo-
calization of the most telomeric probe used by La Starza et al.
[14] is between 12p13.32 and 12p13.33 (D12S158), the
same region as our probe (D12S235).
Subtelomeric regions are interesting from a genomic per-
spective. Although the telomeric regions of human chromo-
somes are believed to have the highest concentration of
genes [20], it has been shown that many nonfunctional
Fig. 2. Examples of SKY and FISH analysis. (A) Partial SKY karyotype of patients 1, 2, 10, and 13. (B) FISH analysis of patient 2 showed that the most telo-
meric probes used are retained. Cosmids 9A4 (red) and 11A1 probe (green) label both normal chromosome 12 and der(12)t(1;12)(q24;p13).
 
Table 1
Partial Giemsa-banded and revised karyotype modified by SKY and FISH of 19 patients with 12p unbalanced translocations
Patient
no. Diagnosis G-banded Karyotype Revised Karyotype
1 AL der(12)t(7;12)(p11;p12) der(12)t(12;13)(p12;q11)
2 ALL der(12)t(1;12)(q24;p13) der(12)t(1;12)(q24;p13.33)
3 ALL dic(9;12)(p13;p11) dic(9;12)(p13;p11)
4 ALL der(12)t(12;15)(p13;q22) der(12)t(12;15)(p13.33;q22)
5 ALL der(12)t(12;17)(p12;q12) der(12)t(12;17)(p12.3;q12)
6 ALL t(4;12)(q21;p13) der(12)t(4;12)(q21;p12)
7 ALL der(12)t(12;17)(p12;q11) der(12)t(12;17)(p12.3;q11)
8 sAML t(6;12)(p21;p12) der(12)t(6;12)(p21;p12)
9 sAML add(12)(p12) der(12)t(3;12)(q?21;p12)
10 AML dic(11;12)(p13;p13)
 

 
del(12)(p12p13) dic(11;12)(p13;p12)
 

 
del(12)(p12p13)
11 sAML der(12)t(6;12)(p22;q24) der(12)del(12)(p12p13.2)t(10;12)(p12;p13.33)
12 AML der(12)t(1;12)(q21;p12) der(12)t(1;12)(q21;p12)
13 AML der(12)t(11;12)(q11;p11) der(12)t(11;12)(q11;p11)
14 sAML der(12)t(12;14)(p13;q11) der(12)t(12;14)(p12;q11)
15 LPD add(12)(p12) der(12)t(12;21)(p13;q?)
16 MDS der(12)t(3;12)(q13;p13) der(12)del(12)(p12p13.2)t(3;12)(q13;p13.33)
17 MDS der(12)t(12;17)(p13;q21) der(12)del(12)(p12p13.2)t(12;17)(p13.33;q21)
18 MDS der(12)t(2;12)(q21;p12) der(12)t(2;12)(q21;p13)
19 MDS add(12)(p13) der(12)del(12)(p12p13.2)t(12;13)(p13.33;q?)
 
Abbreviations
 
: AL, acute leukemia; ALL, acute lymphoid leukemia; AML, acute myelocytic leukemia; LPD, lymphoproliferative disorder (specifically,
mycosis fungoides); MDS, myelodysplastic syndrome; sAML, secondary acute myelocytic leukemia.
 
a
 
Patient 7 is patient 8 in [3]. Patients 1, 9, 10, 11, 12, 13, 14, 16, 18 and 19 are patients 1, 4, 5, 9, 10, 12, 2, 13, 14 and 15, respectively, in [23].
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pseudogenes map to the subtelomeric regions [21,22]. The
pseudogenes and repeat sequences share homology between
nonhomologous chromosomes, providing the opportunity
for nonhomologous telomere pairing, which could lead to
exchange events and gene–dosage imbalance.
Ninety five percent of our patients (18/19) presented with a
complex karyotype. Cases with unbalanced 12p transloca-
tions appear to be closely associated with complex karyo-
types, and in most cases the breakpoints have been reported
to be outside 
 
ETV6,
 
 as was true for all our patients [14,15].
SKY is an important tool to characterize the aberrations in
these cases [23]. Samples with complex aberrations, dele-
tions, and unbalanced translocations are particularly prone
to misinterpretation based on G-banding alone, especially
when chromosomal regions that have a similar G-banding
pattern are involved. In our study, SKY allowed for the
more complete characterization of the karyotype of the leu-
kemia samples (Table 1 and Fig. 2). Our SKY analyses of
11 of the 19 cases have been reported [3,23]. The clinical
features and the karyotype of the remaining 8 cases are
given in Table 2.
Deletions of the short arm of chromosome 12 are fre-
quent cytogenetic findings in hematologic malignancies of
both myelocytic and lymphoid origin [10,11,17,24]. The
smallest region deleted has been delineated by FISH analy-
ses and loss of heterozygosity studies in 12p aberrant hema-
tologic malignancies; this deleted region includes 
 
ETV6
 
 and
 
CDKN1B
 
 [6,11,24]. In a few cases, the deleted region in-
clude 
 
CDKN1B
 
 but not 
 
ETV6
 
, or 
 
ETV6,
 
 but not 
 
CDKN1B
 
[2]. Interestingly, most deletions are interstitial [6,17].
These findings suggest a minimally deleted region on 12p13
located between 
 
ETV6
 
 and 
 
CDKN1B
 
. This genomic region
was recently thoroughly mapped by Baens et al. [25], who
narrowed the commonly deleted region to a 600-kb segment
between 
 
ETV6
 
 and D12S358, excluding 
 
CDKN1B
 
. In our
cases with 12p unbalanced translocations, FISH analysis con-
firmed the hemizygous deletion of the 
 
ETV6
 
 and 
 
CDKN1B
 
genes in 14 (74%) of cases, including 4 with interstitial de-
letions. In the four cases with myelocytic disorders, and in
two patients with ALL (6/19, 31.5%), the fusion with the
partner chromosome was in the subtelomeric region of 12p,
confirming a recurrent breakpoint in this region. These data
confirm our analyses of other complex karyotypes, which
showed that deletion of critical genes often occurs as a con-
sequence of unbalanced translocations [23].
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